Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025 
Castlight Health to Announce Second Quarter 2019 Results
SAN FRANCISCO, July 22, 2019 /PRNewswire/ -- Castlight Health, Inc. (NYSE: CSLT) will release its second quarter 2019 financial results on...
fishbat Explains What to Do If Your Clinical Trial Goes Global
NEW YORK, July 22, 2019 /PRNewswire/ -- Globalization has had a definitive impact on nearly every industry, and, in recent years,...
DLH to Present at the Canaccord Genuity Conference on August 7
ATLANTA, July 22, 2019 /PRNewswire/ -- DLH Holdings Corp. (NASDAQ: DLHC) ("DLH" or the "Company"), a leading provider of innovative healthcare services...
Jaguar Health Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
SAN FRANCISCO, CA / ACCESSWIRE / July 23, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), a...
Innopresso launches Indiegogo campaign for its touchpad-keyboard Mokibo
SEOUL, South Korea, July 23, 2019 /PRNewswire/ -- Innopresso, a member company of the Born2Global Centre, successfully launched its smart...
Dynatronics Partners with US Speedskating to Equip its New Training Facility
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / July 23, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training,...
EastWest USA Received First Batch of Full Spectrum CBD Oil from Azema Sciences for CBD Pet Treats
VANCOUVER, BC / ACCESSWIRE / July 23, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) announces that, further...
NanoVibronix Announces License Agreement with Ideal Medical International Limited for International Distribution of PainShield(R) and UroShield(R)
ELMSFORD, NY / ACCESSWIRE / July 23, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the...
VistaGen Therapeutics Announces USPTO Grant of Patent for Treatment of Depression with Fast-Acting PH10 Neuroactive Nasal Spray
Previously completed Phase 2a clinical study of PH10 demonstrated significant antidepressant effects without psychological side effects or safety concerns after...
Oncolytics Biotech(R) Announces Preliminary AWARE-1 Trial Data Demonstrating Viral Replication and Promotion of Inflammation Following Systemic Administration of Pelareorep When Combined with Tecentriq(R)
Favorable Steering Committee Recommendation for AWARE-1 Early data indicate that T cell clonality may support the development of a biomarker...
YIELD GROWTH Announces Patent Pending Manufacturing Technique Yields High Concentration of Terpenes in Hemp Root Oil
VANCOUVER, BC / ACCESSWIRE / July 23, 2019 / The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (FSE:YG3) is pleased to announce...
Modernizing Medicine Enhances Price Transparency Tools and Practice Management System to Bolster Its Dermatology Suite of Products and Services
Company Also Announces modmed® BOOST, a Comprehensive Approach Combining Technology and Services to Improve Practice Efficiency BOCA RATON, Fla.--(BUSINESS WIRE)--Specialty-specific...
Excellent Preclinical Efficacy Data of Apogenix’ HERA-GITRL Published in Journal for ImmunoTherapy of Cancer
HERA-GITRL Shows Strong Single-Agent Anti-Tumor Activity in Vitro and in Vivo and is Superior to Bivalent Clinical Benchmark Antibody HEIDELBERG,...
MetrioPharm AG: Sven Zimmermann Joins MetrioPharm Management as CFO
- Sven Zimmermann to become Chief Financial Officer of MetrioPharm AG as of 01.08.2019 - Zimmermann has many years of...
Viveve Announces Top-line Results of LIBERATE-International Trial for SUI, Q2 Transition to New U.S. Commercial Model, and Pursuit of Financial and Strategic Alternatives
ENGLEWOOD, CO / ACCESSWIRE / July 22, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
ENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ET
ANN ARBOR, MI / ACCESSWIRE / July 22, 2019 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a developer of...
Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis
Both tested doses of ARQ-151 demonstrated statistically significant superiority over vehicle Favorable safety and tolerability in this patient population ARQ-151...
CPSI Selected by Trio of Montana Hospitals to Manage Community Healthcare Across Care Settings
Facilities Will Utilize EHR and Revenue Cycle Management (RCM) Solutions to Improve Facility Operations MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a...
PAI and BresMed Join Forces to Support Expanded Use of More Advanced Economic Modelling Software, hēRo3
BROOKLINE, Mass. & SHEFFIELD, United Kingdom--(BUSINESS WIRE)--Policy Analysis Inc. (PAI) and BresMed, two leading health-economics and outcomes research consultancies, are...
Glaukos Announces Global Licensing Agreement With Intratus, Inc.
Novel, Non-Invasive Drug Delivery Platform Expands Glaukos’ Portfolio of Sustained Pharmaceutical Systems Includes Lead Candidate for Treatment of Dry Eye...